StoneX Group’s Mustang Bio MBIO Stock Holding History

StoneX Group’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.14K	Buy	+11,604	New	+$6.73K	﹤0.01%	1882
2023 Q1	–	Sell	-20	Closed	-$5.92K	–	771
2022 Q4	$5.92K	Buy	+20	New	+$6.83K	﹤0.01%	587

Other funds holding MBIO

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Cullen/Frost Bankers San Antonio, Texas $10.2B AUM 22.58% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

StoneX Group's MBIO Position: Q3 2026 in Review

StoneX Group opened a new position in Mustang Bio (MBIO) in Q3 2026: 11,604 shares worth $6.14K. The stake represents ﹤0.01% of the portfolio and ranks #1882 among its holdings. This is a return to the name: StoneX Group previously reported a position in MBIO as recently as Q4 2022.

StoneX Group first reported a position in MBIO in Q4 2022 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold MBIO as of Q3 2026.

StoneX Group held 11,604 shares of Mustang Bio worth $6.14K as of Q3 2026.
Mustang Bio was a new StoneX Group position in Q3 2026.
Mustang Bio made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1882 holding.
StoneX Group first reported a position in Mustang Bio in Q4 2022 and has held it in 2 quarters since.
5 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.